Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19

COVID-19 has recently become a major pandemic with associated socioeconomic dimensions. Mortality statistics suggest that COVID-19 is more lethal in aged patients with comorbid conditions including hypertension. There is ongoing debate about whether the use of angiotensin converting enzyme (ACE) inh...

Ausführliche Beschreibung